Navigation Links
MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results
Date:11/12/2008

MOUNTAIN VIEW, Calif., Nov. 12 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced financial results for the third quarter ended September 30, 2008.

The net loss for the third quarter ended September 30, 2008 was $20.4 million compared with $9.8 million during the same period in 2007. The net loss for the nine months ended September 30, 2008 was $51.1 million compared to $25.2 million for the nine months ended September 30, 2007. As of September 30, 2008, MAP Pharmaceuticals had cash, cash equivalents and short-term investments of $63.0 million.

"We had a very busy and productive third quarter with two active Phase 3 clinical programs ongoing. We completed patient enrollment of our Phase 3 trial of Unit Dose Budesonide, or UDB, for the potential treatment of pediatric asthma, and continued enrollment of our Phase 3 trial of MAP0004 for the potential treatment of migraine," said Timothy S. Nelson, President and Chief Executive Officer of MAP Pharmaceuticals. "In this environment, we continue to manage our resources prudently as we advance toward our goal of commercializing clearly differentiated products that address major market opportunities."

Third Quarter 2008 and Recent Accomplishments

Clinical development

-- UDB: Completed enrollment and randomized approximately 360 patients in a Phase 3 clinical trial to evaluate UDB for the potential treatment of pediatric asthma. The last patient in this trial is expected to complete the 12-week treatment period by the end of 2008.

-- MAP0004: Initiated enrollment in a Phase 3 clinical trial to evaluate MAP0004 for the potential treatment of migraine, pursuant to a Special Protocol Assessment with the U.S. Food and Drug Admin
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
2. Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts
3. Jazz Pharmaceuticals, Inc. to Announce Third Quarter Financial Results on November 13, 2008
4. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2008 Financial Results
5. MAP Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
6. Keryx Biopharmaceuticals KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology
7. Duska Therapeutics and DSM Pharmaceuticals in Manufacturing Collaboration for PSVT Drug Product
8. Memory Pharmaceuticals Announces Six Abstracts Accepted for Presentation at Society for Neuroscience Meeting
9. Alseres Pharmaceuticals, Inc. To Host Third Quarter 2008 Conference Call
10. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2008 Financial Results on Tuesday, November 11, at 8:30 A.M. EST
11. Sagent Pharmaceuticals Announces Presentations at Upcoming Lazard Capital Markets and Piper Jaffray Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/17/2014)... 2014 A Diet Doc in-house ... the country are turning back the clock on aging, ... is because the company has recently added their prescription ... collection of prescription and non-prescription diet products and healthy ... Doc’s best anti-aging human growth hormone therapy ...
(Date:11/17/2014)... World Food Processing announced today that ... American Farmer airing via RFD-TV 2nd QTR 2015. American ... RFD-TV. , World Food Processing is a sustainable solution ... unique system provides a secure system, supplying non-GMO and ... segment will educate viewers about World Food Processing’s unparalleled ...
(Date:11/17/2014)... 2014 QuickChek customers and employees demonstrated ... “Dog Tag” Promotion. In total, the New Jersey ... Warriors® in support of military families both locally and ... nonprofit dedicated to restoring a sense of self, restoring ... members and our military families. , Throughout the ...
(Date:11/17/2014)... For the first time in medical history, ... a single cell extracted from a 3-day-old embryo to ... family. Double-board certified expert Maher Abdallah, M.D. of American ... implanted only the healthy embryos that, in turn, led ... Vitro Fertilization has taken a giant step forward with ...
(Date:11/17/2014)... Wright & Schulte LLC reports that a federal ... pay a total of $28.7 million in compensatory damages ... they suffered injuries that included bleeding, pain, and infection ... reported that jurors also found Boston Scientific's Pinnacle pelvic ... to warn physicians and their patients about the ...
Breaking Medicine News(10 mins):Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 2Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 3Health News:American Farmer to Feature World Food Processing in 2015 Series 2Health News:QuickChek Gives Big Support to Hope For The Warriors One Dollar at a Time 2Health News:IVF Specialist From American Reproductive Centers Performs World's First DNA Sequencing On Single Cell So Defected Genes Won't Be Passed To Future Generations 2Health News:Boston Scientific Ordered To Pay $28.7 Million In Bladder Mesh Lawsuits After Injuries From Pelvic Mesh Implant Reports Wright & Schulte LLC 2Health News:Boston Scientific Ordered To Pay $28.7 Million In Bladder Mesh Lawsuits After Injuries From Pelvic Mesh Implant Reports Wright & Schulte LLC 3Health News:Boston Scientific Ordered To Pay $28.7 Million In Bladder Mesh Lawsuits After Injuries From Pelvic Mesh Implant Reports Wright & Schulte LLC 4
... Gordon HealthDay Reporter , MONDAY, Aug. 23 (HealthDay ... or both parents are aggressive or violent toward each other ... The study found that 65 percent of 3-year-olds were spanked ... that reported parental aggression toward another parent, the use of ...
... researchers are reporting on the discovery of a bug with ... the researchers questioning whether they could believe their own eyes. ... demonstration of truly bifocal lenses in the extant animal kingdom," ... the premier life-science journal, Current Biology . The ...
... new analysis has found that while colon cancer rates have ... the age of 40, rectal cancer rates are increasing in ... online in Cancer , a peer-reviewed journal of the ... needed to diagnose rectal cancer in young individuals who show ...
... By Steven Reinberg HealthDay Reporter , FRIDAY, ... cigarette now and then can,t hurt, right? Wrong, according ... smoke exposure can cause irreparable damage to cells essential to ... after exposure to secondhand smoke. The initial damage, while not ...
... , FRIDAY, Aug. 20 (HealthDay News) -- Folks have been taught ... hat on their heads to protect their skin from the sun,s ... pair of good sunglasses to the ensemble still leaves people at ... significant damage to unprotected eyes, resulting in a number of illnesses ...
... Elsevier Health Sciences and Helinet, India,s premier ... agreement that will provide all medical students at ... and local medical content through Elsevier,s electronic platforms: ... agreement provides all undergraduates, graduates, researchers and faculty ...
Cached Medicine News:Health News:Parents Who Clash More Likely to Spank Kids 2Health News:Parents Who Clash More Likely to Spank Kids 3Health News:Researchers gain focus on a bug with bifocals 2Health News:Rectal cancer rates are rising in young individuals 2Health News:Study Finds Even a Little Cigarette Smoke Harms Airway 2Health News:Study Finds Even a Little Cigarette Smoke Harms Airway 3Health News:Sunglasses Rival Lotions as Vital for Safety 2Health News:Sunglasses Rival Lotions as Vital for Safety 3
(Date:11/18/2014)... SAN DIEGO , Nov. 18, 2014 ... stage biopharmaceutical company that discovers, develops and plans ... announced today that it filed an Investigational New ... Drug Administration (FDA) on Friday, November 14, 2014.  ... clinical development of a patented formulation of the ...
(Date:11/18/2014)... Nov. 18, 2014 SynCardia Systems, Inc., has ... Award for Small Companies presented by the Arizona Technology ... The 11th annual Governor,s Celebration of Innovation Awards ... . Arizona Governor ... ceremony. SynCardia was honored for its Freedom® portable driver, ...
(Date:11/18/2014)... 2014  Nopras Technologies ( www.nopras-tech.com ) has ... to the position of Director, Business Development ... from Bio-Investigations Ltd., a specialized global venture capital ... years ago, focused in the fields of human, ... graduate degrees in biology, biochemistry, and business from ...
Breaking Medicine Technology:HedgePath Pharmaceuticals Files IND Application 2HedgePath Pharmaceuticals Files IND Application 3HedgePath Pharmaceuticals Files IND Application 4SynCardia Named Innovator of the Year by the 2014 Governor's Celebration of Innovation Awards for Its Freedom Portable Driver 2SynCardia Named Innovator of the Year by the 2014 Governor's Celebration of Innovation Awards for Its Freedom Portable Driver 3Nopras Technologies Inc. Appoints Director Of Business Development - East Coast Operations 2Nopras Technologies Inc. Appoints Director Of Business Development - East Coast Operations 3
... , SAN FRANCISCO, Nov. 18 Epiphany ... of EPB-348 (valomaciclovir) in patients with shingles (herpes zoster) ... once-daily valomaciclovir compared to thrice-daily valacyclovir in terms of ... The double-blinded study enrolled 373 patients, randomized into 3 ...
... , PRINCETON, N.J., Nov. 18 Covance ... drug development services, announced today that it entered into a ... a leading provider of multiplexed protein biomarker testing to the ... Covance will use RBM as its exclusive third-party provider of ...
Cached Medicine Technology:Epiphany Announces Positive Results from Its Phase 2b Trial in Shingles. 2Epiphany Announces Positive Results from Its Phase 2b Trial in Shingles. 3Covance Enters Into a Biomarker Alliance With Rules-Based Medicine, Inc. 2Covance Enters Into a Biomarker Alliance With Rules-Based Medicine, Inc. 3Covance Enters Into a Biomarker Alliance With Rules-Based Medicine, Inc. 4
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Medicine Products: